Category: CovidienSyndicate content

Abbott to expand medical device footprint? | Medtech Wall Street news for the week of May 12, 2014

May 15, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott may look to expand medical device business footprint; Device makers take big writedowns on renal denervation; Cardinal Health closes $320M AccessClosure buy; K2M prices IPO under range at $132M; Allergan board spurns Valeant's $47B offer.

Abbott may look to expand medical device business footprint

May 9, 2014 by Brad Perriello

Abbott may look to expand medical device business footprint

Device makers take big writedowns on renal denervation

May 13, 2014 by Brad Perriello

Boston Scientific, Medtronic and Covidien take millions in write-downs on their renal denervation assets after the failure of Medtronic's Symplicity-3 trial.

Device makers take big writedowns on renal denervation

Confirmed: Covidien acquires Zephyr's wearable monitors

May 5, 2014 by Arezu Sarvestani

MobiHealthNews reports that medtech titan Covidien acquired Zephyr Technology, maker of wireless patient monitors.

Report: Covidien acquires Zephyr's wearable monitors

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech trends: The most talked about device makers in April 2014

May 2, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien beats The Street by 1¢ in Q2

April 25, 2014 by Arezu Sarvestani

Medtech giant Covidien posts modest top and bottom-line gains for its 1st quarter following the $860 million acquisition of Given Imaging.

Coviden beats The Street by 1¢ in Q2

Ireland-based medtech maker Covidien (NYSE:COV) posted the results from its latest quarter, spurring a 2.2% drop in the company's shares.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA: Covidien Pipeline recall is Class I

April 21, 2014 by Brad Perriello

The FDA slaps Covidien's recall of its Pipeline and Alligator brain aneurysm devices with Class I status, denoting the potential for serious injury or death.

Covidien recalls Pipeline, Alligator brain aneurysm devices

The FDA today gave the recall by Covidien (NYSE:COV) of some of its Pipeline and Alligator brain aneurysm devices earlier this month Class I status, its most serious recall category.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien lands FDA OK for camera-equipped feeding tube

April 18, 2014 by Arezu Sarvestani

Covidien touts FDA clearance for its novel camera-equipped Kangaroo feeding tube designed to provide visualization for an otherwise blind procedure.

Covidien lands FDA OK for camera-equipped feeding tube

Medtech titan Covidien (NYSE:COV) received FDA clearance for its visual Kangaroo feeding tube, equipped with an endoscopic camera that allows physicians to see into the procedure in a new way.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp